医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

USP

Dr. Reddy’s Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market

Dr. Reddy’s Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market

バイオテクノロジーヘルスケア腫瘍学製薬　 TimeLine: Market Reddy's Laboratories Announces the Launch sorafenib Tablets USP

2022年06月14日

Dr. Reddy’s Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market

Dr. Reddy’s Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market

その他ヘルスヘルスケア製薬　 TimeLine: announce the launch Inc Market Reddy's Laboratories and Senores Pharmaceuticals USP

2022年05月25日

Dr. Reddy’s Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market

ヘルスケア製薬　 TimeLine: Market Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT USP vasopressin injection

2022年02月09日

Dr. Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve® in the U.S. Market

ヘルスケア製薬　 TimeLine: Market mg Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets Store-Brand Equivalent of Aleve USP

2021年08月03日

Dr. Reddy’s announces the re-launch of over-the-counter Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid AC® in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Market of over-the-counter Famotidine Tablets Reddy’s announces the re-launch store-brand equivalent USP

2020年10月20日

Dr. Reddy’s announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday®, the Eye Allergy Drop in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Market of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution Reddy’s announces the launch the store-brand equivalent USP

2020年09月17日

Dr. Reddy’s Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Market Methylphenidate Hydrochloride Extended-Release Tablets Reddy's Laboratories Announces the Launch USP

2020年09月03日

Dr. Reddy’s Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Market of Penicillamine Capsules Reddy's Laboratories Announces the Launch USP

2020年08月27日

Dr. Reddy’s Laboratories Announces the Launch of Colchicine Tablets USP, 0.6 mg in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Colchicine Tablets USP, 0.6 mg in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Market Reddy's Laboratories Announces the Launch of Colchicine Tablets USP

2020年06月12日

Dr. Reddy’s Laboratories Announces the Launch of Fenofibrate Tablets USP, in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Fenofibrate Tablets USP, in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Market Reddy's Laboratories Announces the Launch of Fenofibrate Tablets USP

2020年04月27日